These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17763287)

  • 1. An immunohistochemical approach to differentiate hepatic lipidosis from hepatic phospholipidosis in rats.
    Obert LA; Sobocinski GP; Bobrowski WF; Metz AL; Rolsma MD; Altrogge DM; Dunstan RW
    Toxicol Pathol; 2007 Aug; 35(5):728-34. PubMed ID: 17763287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry of LAMP-2 and adipophilin for phospholipidosis in liver and kidney in ketoconazole-treated mice.
    Asaoka Y; Togashi Y; Imura N; Sai T; Miyoshi T; Miyamoto Y
    Exp Toxicol Pathol; 2013 Sep; 65(6):817-23. PubMed ID: 23276623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Immunohistochemical Investigation of Renal Phospholipidosis and Toxicity in Rats.
    Ma JY; Snook S; Garrovillo S; Johnson C; La D
    Int J Toxicol; 2017; 36(5):386-394. PubMed ID: 28820006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Application of Paraphenylenediamine Staining for Assessment of Phospholipidosis.
    Shirai N; Geoly FJ; Bobrowski WF; Okerberg C
    Toxicol Pathol; 2016 Dec; 44(8):1160-1165. PubMed ID: 27770109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining for adipophilin, perilipin and TIP47.
    Muthusamy K; Halbert G; Roberts F
    J Clin Pathol; 2006 Nov; 59(11):1166-70. PubMed ID: 16556662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical flow cytometric biomarker strategy: validation of peripheral leukocyte phospholipidosis using Nile red.
    Halstead BW; Zwickl CM; Morgan RE; Monteith DK; Thomas CE; Bowers RK; Berridge BR
    J Appl Toxicol; 2006; 26(2):169-77. PubMed ID: 16278808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864.
    Rudmann DG; McNerney ME; VanderEide SL; Schemmer JK; Eversole RR; Vonderfecht SL
    Toxicol Pathol; 2004; 32(3):326-32. PubMed ID: 15204974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel set of biomarkers for evaluating phospholipidosis-inducing potential of compounds using rat liver microarray data measured 24-h after single dose administration.
    Yudate HT; Kai T; Aoki M; Minowa Y; Yamada T; Kimura T; Ono A; Yamada H; Ohno Y; Urushidani T
    Toxicology; 2012 May; 295(1-3):1-7. PubMed ID: 22426296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipidosis assay in HepG2 cells and rat or rhesus hepatocytes using phospholipid probe NBD-PE.
    Bhandari N; Figueroa DJ; Lawrence JW; Gerhold DL
    Assay Drug Dev Technol; 2008 Jun; 6(3):407-19. PubMed ID: 18537465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible, hepatic, lysosomal phospholipidosis in rat induced by subchronic daily administration of trospectomycin sulfate.
    Cox JW; Ulrich RG; Wynalda MA; McKenna R; Larsen ER; Ginsberg LC; Epps DE
    Biochem Pharmacol; 1989 Oct; 38(20):3535-41. PubMed ID: 2530987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of 3D Human Liver Organoids to Predict Drug-Induced Phospholipidosis.
    Lee JY; Han HJ; Lee SJ; Cho EH; Lee HB; Seok JH; Lim HS; Son WC
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead-induced phospholipidosis and cholesterogenesis in rat tissues.
    Ademuyiwa O; Agarwal R; Chandra R; Behari JR
    Chem Biol Interact; 2009 May; 179(2-3):314-20. PubMed ID: 19056365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipidosis effect of drugs by adsorption into lipid monolayers.
    Ceccarelli M; Germani R; Massari S; Petit C; Nurisso A; Wolfender JL; Goracci L
    Colloids Surf B Biointerfaces; 2015 Dec; 136():175-84. PubMed ID: 26387069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced phospholipidosis: are there functional consequences?
    Reasor MJ; Kacew S
    Exp Biol Med (Maywood); 2001 Oct; 226(9):825-30. PubMed ID: 11568304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Mass Microscopy of Kidneys from Azithromycin-Treated Rats with Phospholipidosis.
    Sakurai T; Kamio K; Sasaki K; Nishimoto T; Yamaguchi JI; Sasaki M; Tsutsumi S
    Am J Pathol; 2018 Sep; 188(9):1993-2003. PubMed ID: 29981744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.
    McCloud CM; Beard TL; Kacew S; Reasor MJ
    Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized phospholipidosis induced by an amphiphilic cationic psychotropic drug.
    Robison RL; Visscher GE; Roberts SA; Engstrom RG; Hartman HA; Ballard FH
    Toxicol Pathol; 1985; 13(4):335-48. PubMed ID: 3834585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.
    Sawada H; Takami K; Asahi S
    Toxicol Sci; 2005 Feb; 83(2):282-92. PubMed ID: 15342952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental phospholipidosis induced by 4,4'-diethyl-aminoethoxyhexestrol. Morphological and biochemical interpretations.
    Tashiro Y; Watanabe Y; Enomoto Y
    Acta Pathol Jpn; 1983 Sep; 33(5):929-42. PubMed ID: 6316720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical determination of hepatic cytochrome P-4502E1 in formalin-fixed, paraffin-embedded sections.
    Cohen PA; Mak KM; Rosman AS; Kessova I; Mishin VM; Koivisto T; Lieber CS
    Alcohol Clin Exp Res; 1997 Sep; 21(6):1057-62. PubMed ID: 9309318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.